Acute Porphyria Drug Database

Monograph

J01DB01 - Cefalexin
Propably not porphyrinogenic
PNP

Rationale
Not metabolised. No data pointing to CYP interaction.
Chemical description
Perorally used cephalosporin (500 mg x 2) antibiotic used in uncomplicated urinary tract infections, skin and soft tissue infections and in pharyngotonsillitis where penicillin V has shown to be without effect. No data pointing to CYP-interaction. Excreted in unchanged form by the kidneys. South African list: use with caution. Australian list: unsafe, conflicting evidence. Drug Consult: safe.
IPNet drug reports
Uneventful use reported in 8 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes J01D / J01DB or go back.
Tradenames
This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.


Keforal Keforal Cefalexina · Kefloridina Forte · Torlasporin Ceporex · Keforal Cefalexina · Keflex Cefalexin · Ceporex · Keflex Keflex Keflex Cefaleksyna Keforal Keflex Kefalex · Kefexin · Xefal Cefaleksin · Cefalexin · Palitrex
 
© NAPOS 2025
An unhandled error has occurred. Reload 🗙